Hormone and Cytokine Regulation of Endotoxin Injury

内毒素损伤的激素和细胞因子调节

基本信息

项目摘要

DESCRIPTION (provided by applicant): Severe injury and infection are leading causes of morbidity and mortality among adults. Such severe conditions evoke both pro-inflammatory and anti-inflammatory responses at the systemic and tissue levels. While systemic anti-inflammation is directed initially by hormonal and autonomic influences, the effectiveness of these systemic anti-inflammatory mechanisms dissipates during prolonged stressful conditions. In the context of a subsequent (e.g. infectious) challenge, alternative anti-inflammatory pathway(s) must compensate for the diminished regulatory influences exerted by endocrine hormones, such as cortisol and catecholamines. In the current proposal, we hypothesize that competent vagal autonomic pathways assume greater significance for dampening inflammatory stress during prolonged recovery. In modeling the human reponse to initially sterile (hormone infusion) and subsequent inflammatory (endotoxinemia) stressors, we have noted a diminution of endocrine mediated anti-inflammatory responsiveness. Hence, we propose that any acquired vagal autonomic dysfunction (VAD) becomes a limiting factor for dampening pro-inflammatory responses to secondary stressful stimulus, such as endotoxin. In Specifc Aim #1, we will A) model a period of sterile stress (via stress hormone infusion) to ascertain the role of vagal autonomic function (by heart rate variability determinations) upon endotoxin-induced systemic pro- and anti-inflammatory responses in humans. We also will, B) utilize an agonist of the vagal cholinergic anti-inflammatory pathway to ascertain the influence of this agent upon inflammatory responses to endotoxin following a period of hormone stress. We have recently documented acquired VAD during intestinal nutrient deprivation. In Specifc Aim #2, we will utilize this human model to ascertain acute intestinal nutrient (high-fat) stimulation on vagal tone and the response to endotoxin. In Specific Aim #3, we will determine the incidence and consequences of sterile stress (trauma and surgery) induced alterations of inflammatory balance and VAD in critically-ill patients at risk for a secondary stimulus, such as infection and/or organ failure. Relevance to Public Health: The proposed studies will clarify the clinical contexts in which vagal autonomic dysfunction contributes to morbidity and mortality in severely stressed patients. The proposed low-risk interventions will also define opportunities to enhance vagally regulated anti-inflammatory responses.
描述(由申请人提供):严重伤害和感染是成年人发病和死亡率的主要原因。这种严重的条件引起了全身和组织水平上的促炎和抗炎反应。尽管最初是由荷尔蒙和自主性影响指导的全身性抗炎,但这些全身性抗炎机制的有效性在长期的压力条件下消散了。在随后的(例如传染性)挑战的背景下,替代性抗炎途径必须弥补内分泌激素(例如皮质醇和儿童胺)所施加的调节性影响减少。在当前的提案中,我们假设有能力的迷走神经自主神经途径对长期恢复过程中炎症压力的抑制作用具有更大的意义。在建模人类对最初无菌(激素输注)和随后的炎症(内毒素血症)应激源的响应时,我们注意到内分泌介导的抗炎反应性的减少。因此,我们建议任何获得的迷走神经自主神经功能障碍(VAD)成为抑制对继发性压力刺激(例如内毒素)促炎反应的限制因素。在指定目标#1中,我们将a)模拟一个无菌应力时期(通过压力激素输注),以确定迷走神经自主神经功能(通过心率可变性确定)对内毒素诱导的人类系统性和抗炎反应的作用。 b)我们还将利用迷走神经能抗炎途径的激动剂来确定该药物对激素胁迫后对内毒素的炎症反应的影响。我们最近记录了在肠道营养剥夺期间获得的VAD。在指定目标#2中,我们将利用这种人类模型来确定迷走神经张力的急性肠道营养(高脂)刺激和对内毒素的反应。在特定的目标#3中,我们将确定无菌应激(创伤和手术)的发病率和后果诱导的炎症平衡和VAD的改变,对有继发性刺激的风险,例如感染和/或器官衰竭。与公共卫生的相关性:拟议的研究将阐明迷走神经自主神经功能障碍有助于严重压力患者的发病率和死亡率的临床环境。拟议的低风险干预措施还将定义机会,以增强模糊调节的抗炎反应。

项目成果

期刊论文数量(156)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
IL-8 in septic shock, endotoxemia, and after IL-1 administration.
  • DOI:
    10.4049/jimmunol.146.10.3478
  • 发表时间:
    1991-05
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    K. Zee;L. Deforge;E. Fischer;M. Marano;J. Kenney;D. Remick;S. Lowry;L. Moldawer
  • 通讯作者:
    K. Zee;L. Deforge;E. Fischer;M. Marano;J. Kenney;D. Remick;S. Lowry;L. Moldawer
Interleukin-1 contributes to increased concentrations of soluble tumor necrosis factor receptor type I in sepsis.
在脓毒症中,IL-1 有助于增加 I 型可溶性肿瘤坏死因子受体的浓度。
  • DOI:
    10.1093/infdis/172.2.577
  • 发表时间:
    1995
  • 期刊:
  • 影响因子:
    0
  • 作者:
    vanderPoll,T;Fischer,E;Coyle,SM;VanZee,KJ;Pribble,JP;Stiles,DM;Barie,PS;Buurman,WA;Moldawer,LL;Lowry,SF
  • 通讯作者:
    Lowry,SF
Translational applications of evaluating physiologic variability in human endotoxemia.
  • DOI:
    10.1007/s10877-012-9418-1
  • 发表时间:
    2013-08
  • 期刊:
  • 影响因子:
    2.2
  • 作者:
    Scheff, Jeremy D.;Mavroudis, Panteleimon D.;Calvano, Steve E.;Androulakis, Ioannis P.
  • 通讯作者:
    Androulakis, Ioannis P.
Thermogenic and nitrogen response to submaximal exercise in parenterally repleted normal man.
正常人肠胃外补充后对次最大运动的生热和氮反应。
Neutralization of TNF does not influence endotoxininduced changes in thyroid hormone metabolism in humans.
TNF 的中和不会影响内毒素引起的人类甲状腺激素代谢变化。
  • DOI:
    10.1152/ajpregu.1999.276.2.r357
  • 发表时间:
    1999
  • 期刊:
  • 影响因子:
    0
  • 作者:
    vanderPoll,T;Endert,E;Coyle,SM;Agosti,JM;Lowry,SF
  • 通讯作者:
    Lowry,SF
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SIOBHAN A CORBETT其他文献

SIOBHAN A CORBETT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SIOBHAN A CORBETT', 18)}}的其他基金

FIBRONECTIN-MEDIATED CELL SIGNALING IN WOUND HEALING
伤口愈合中纤连蛋白介导的细胞信号传导
  • 批准号:
    6520319
  • 财政年份:
    2000
  • 资助金额:
    $ 21万
  • 项目类别:
The Regulation of Fibronectin Matrix Assembly in Wound Healing
纤连蛋白基质组装在伤口愈合中的调控
  • 批准号:
    7251496
  • 财政年份:
    2000
  • 资助金额:
    $ 21万
  • 项目类别:
FIBRONECTIN-MEDIATED CELL SIGNALING IN WOUND HEALING
伤口愈合中纤连蛋白介导的细胞信号传导
  • 批准号:
    6757260
  • 财政年份:
    2000
  • 资助金额:
    $ 21万
  • 项目类别:
FIBRONECTIN-MEDIATED CELL SIGNALING IN WOUND HEALING
伤口愈合中纤连蛋白介导的细胞信号传导
  • 批准号:
    6636506
  • 财政年份:
    2000
  • 资助金额:
    $ 21万
  • 项目类别:
The Regulation of Fibronectin Matrix Assembly in Wound Healing
纤连蛋白基质组装在伤口愈合中的调控
  • 批准号:
    6983836
  • 财政年份:
    2000
  • 资助金额:
    $ 21万
  • 项目类别:
FIBRONECTIN-MEDIATED CELL SIGNALING IN WOUND HEALING
伤口愈合中纤连蛋白介导的细胞信号传导
  • 批准号:
    6190308
  • 财政年份:
    2000
  • 资助金额:
    $ 21万
  • 项目类别:
FIBRONECTIN-MEDIATED CELL SIGNALING IN WOUND HEALING
伤口愈合中纤连蛋白介导的细胞信号传导
  • 批准号:
    6387242
  • 财政年份:
    2000
  • 资助金额:
    $ 21万
  • 项目类别:
The Regulation of Fibronectin Matrix Assembly in Wound Healing
纤连蛋白基质组装在伤口愈合中的调控
  • 批准号:
    7082232
  • 财政年份:
    2000
  • 资助金额:
    $ 21万
  • 项目类别:
Hormone and Cytokine Regulation of Endotoxin Injury
内毒素损伤的激素和细胞因子调节
  • 批准号:
    7798235
  • 财政年份:
    1985
  • 资助金额:
    $ 21万
  • 项目类别:

相似国自然基金

成人型弥漫性胶质瘤患者语言功能可塑性研究
  • 批准号:
    82303926
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
  • 批准号:
    82302025
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
  • 批准号:
    82302311
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Formation of a functional tendon enthesis during development and healing
在发育和愈合过程中形成功能性肌腱附着点
  • 批准号:
    10587399
  • 财政年份:
    2023
  • 资助金额:
    $ 21万
  • 项目类别:
Microglial process convergence following brain injury
脑损伤后小胶质细胞过程收敛
  • 批准号:
    10657968
  • 财政年份:
    2023
  • 资助金额:
    $ 21万
  • 项目类别:
Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis
共生表皮葡萄球菌预防糖尿病伤口细胞内感染
  • 批准号:
    10679628
  • 财政年份:
    2023
  • 资助金额:
    $ 21万
  • 项目类别:
Fast-kinetics approaches to define direct gene-regulatory functions of MYB in leukemia
快速动力学方法定义 MYB 在白血病中的直接基因调控功能
  • 批准号:
    10644259
  • 财政年份:
    2023
  • 资助金额:
    $ 21万
  • 项目类别:
Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
大剂量口服孟鲁司特的剂量递增临床试验为哮喘急性发作儿童的未来随机对照试验提供信息
  • 批准号:
    10649012
  • 财政年份:
    2023
  • 资助金额:
    $ 21万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了